Low dose HSP90 inhibition with AUY922 blunts rapid evolution of metastatic and drug resistant phenotypes induced by TGF-β and paclitaxel in A549 cells-Reference-Cited by-同舟云学术

Low dose HSP90 inhibition with AUY922 blunts rapid evolution of metastatic and drug resistant phenotypes induced by TGF-β and paclitaxel in A549 cells

Published:2020-09 Issue: Volume:129 Page:110434
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Bacon Nickolas A.,Larre Isabel,Lawag Abdalla A.,Merritt Carlen,Smith Mackinzie,Rosolen Matthew,Sollars Vincent E.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference44 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

3. Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting?;Sosa Iglesias;Front. Oncol.,2018

4. Drug resistance in lung cancer;Shanker;Lung Cancer (Auckl),2010

5. Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers;Volm;Br. J. Cancer,1991

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AUY922 improves sensitivity to sunitinib in clear cell renal cell carcinoma based on network pharmacology and in vitro experiments;Heliyon;2024-07

2. HSP90: A promising target for NSCLC treatments;European Journal of Pharmacology;2024-03

3. LGALS3BP is a novel and potential biomarker in clear cell renal cell carcinoma;Aging;2024-02-22

4. DRdriver: identifying drug resistance driver genes using individual-specific gene regulatory network;Briefings in Bioinformatics;2023-03

5. Ferroptosis as a Potential Cell Death Mechanism against Cisplatin-Resistant Lung Cancer Cell Line;Advanced Pharmaceutical Bulletin;2021-11-07